Risk Factor Of Substitution ARV First Line People Living With HIV/AIDS In General Hospital Buleleng Bali

Keywords: Substitution, First Line, Buleleng

Abstract

Substitution is still a threat to the failure of ARV therapy so that no matter how small it must be noted and monitored in ARV therapy. The aims  was analysis risk factor substitution ARV first line in therapy ARV. This study was an analytic longitudinal study with retrospective secondary data analysis in a cohort of patients receiving ARV therapy at the District General Hospital of Buleleng District for the period of 2006-2015 and secondary data from medical records of PLHA patients receiving ART.  Result in this study that the percentage of first-line ARV substitution events is 9.88% (119/1204) who received ARV therapy for the past 11 years. Risk factors that increase the risk of substitution in ARV therapy patients are zidovudine (aOR 4.29 CI 1.31 -2.65 p 0.01), nevirapine (aOR1.86 CI 2.15 - 8.59 p 0.01) and functional working status (aOR 1.46 CI 1.13 - 1.98 p 0.01). 

Author Biographies

Gusti Putu Candra, STIKES BULELENG

Farmacy

Putu Dian Prima Kusuma Dewi, STIKES BULELENG

midwifery

I Made Sundayana, STIKES BULELENG

nursing

Indrie Lutfiana, STIKES BULELENG

midwifery

Published
2020-05-03
How to Cite
Puspaningrat, L. P., Candra, G., Kusuma Dewi, P. D., Sundayana, I. M., & Lutfiana, I. (2020). Risk Factor Of Substitution ARV First Line People Living With HIV/AIDS In General Hospital Buleleng Bali. STRADA Jurnal Ilmiah Kesehatan, 9(1), 190-197. https://doi.org/10.30994/sjik.v9i1.240